ALTCOIN ETF WATCH: NOVEMBER 2026 Here are the altcoins gaining new ETF exposure through November filings and registration updates. 1. NEW COIN DESK REVENUE LEADERS ETF Filed November 6 by Defiance, this ETF tracks an index of crypto assets selected for onchain revenue generation and value redistribution to token holders. Its index constituents: • $HYPE • $PUMP • $TRX • $UNI • $AERO • $LINK • $ETH • $LIT • $ASTER • $SOL 2. INJECTIVE ($INJ) Canary filed an amended registration on November 2. The SEC declared the registration effective November 4, and Nasdaq began trading the ETF on November 5. Ticker: INJC 3. CRYPTO MARKET-CAP BASKET Cryptex submitted an amended S-1 on November 10 for its Digital Market Cap ETF. Ticker: BAGZ This provides diversified crypto exposure rather than targeting one individual altcoin. 4. REX-OSPREY CRYPTO INDEX ETFs A November 12 SEC amendment reset the proposed effective date to December 11 for previously registered products, including: • Top 10 Crypto Index ETF • Top 10 Ex-BTC Crypto Index ETF • Top 10 Capped Weightings Crypto Index ETF ETF expansion is moving beyond BTC and ETH. Injective is already trading through a dedicated ETF, while new index products are expanding access to several other crypto assets. The next thing to watch is which individual altcoins attract fresh standalone ETF applications.
Dami-DefiShare

Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.



